
    
      This pilot trial is designed to investigate the benefits of the use of mixtures of probiotics
      isolated from human milk in GUT microbiota development and/or immunological biomarkers.
      Furthermore, the relationship between evaluated parameters and the clinical status of very
      low birth weight preterms during their first weeks of life at the NICU will be analysed.
    
  